Autoscribe Opens Office to Support Expanding BioHub
News Oct 23, 2015
Based in Alderley Park in Cheshire the office will supply and support laboratory and business information systems management to customers across the north of the country.
Established by AstraZeneca the BioHub in Alderley Park acts as a bioscience incubator for over 100 pharmaceutical and life science Companies. It allows them to take advantage of the world class facilities at Alderley Park including laboratories with access to high end equipment through AstraZeneca, as well as on-site business support and staff facilities including a gym and restaurant.
“Our new northern office in Alderley Park allows us to better serve our expanding list of Laboratory Informatics Management System (LIMS) customers across the UK. It’s exciting to be part of the vibrant and fast expanding ecosystem of businesses in the Biohub, all of which will require laboratory management solutions as their businesses expand” said John Boother, Managing Director of Autoscribe Informatics. “Our Matrix Gemini LIMS solution is ideal for businesses in the Biohub as it easily scales from a single seat to global deployment, while its legendary configurability enables it to be easily adapted to suit changing business needs”.
Getting to Know the Microbes that Drive Climate ChangeNews
A new understanding of the microbes and viruses in the thawing permafrost in Sweden may help scientists better predict the pace of climate change.READ MORE
How Many People Die From TB Every Year?News
Discrepancies between the estimates for global tuberculosis deaths is due to different methodologies and data sources used by each institution. The results highlight the need to improve the modeling approaches in these countries in order to understand the true burden of the disease and design adequate health policies.READ MORE
ExPecto Patronum! Magical Machine Learning Tool Summons DNA Dark Matter DataNews
A new machine learning framework, dubbed ExPecto, can predict the effects of mutations in the so-called “dark matter” regions of the human genome. ExPecto pinpoints how mutations can disrupt the way genes turn on and off throughout your body.